Director Kathleen Starkoff granted 5,626 GENTEX (GNTX) shares, holdings now 36,770

Rhea-AI Filing Summary

Starkoff Kathleen reported acquisition or exercise transactions in this Form 4 filing.

GENTEX CORP director Kathleen Starkoff reported receiving a stock award of 5,626 shares of Common Stock as a compensation-related grant. The shares were awarded at no cash cost and increase her direct holdings to 36,770 shares following the transaction. According to the disclosure, the entire award vests 100% one year from the grant award date, meaning she will gain full ownership after the one-year vesting period.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Starkoff Kathleen

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	5,626	$0.00	--

Holdings After Transaction: Common Stock — 36,770 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Stock grant size: 5,626 shares Grant price per share: $0.0000 per share Total shares after transaction: 36,770 shares +1 more

4 metrics

Stock grant size 5,626 shares Common Stock grant coded as acquisition (A)

Grant price per share $0.0000 per share Reported transaction price for the stock award

Total shares after transaction 36,770 shares Director’s direct holdings following the grant

Vesting schedule 100% after one year Shares vest 100% one year from grant award date

Key Terms

Grant, award, or other acquisition, Common Stock, vest 100% one year from grant award date

3 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Common Stock financial

"security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

vest 100% one year from grant award date financial

"These shares vest 100% one year from grant award date."

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Starkoff Kathleen

(Last) (First) (Middle)

600 NORTH CENTENNIAL STREET

(Street)

ZEELAND MICHIGAN 49464

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GENTEX CORP [ GNTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/21/2026		A		5,626(1)	A	$0.00	36,770	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares vest 100% one year from grant award date.

Remarks:

	/s/ Scott Ryan for Kathleen Starkoff by Power of Attorney	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did GENTEX CORP (GNTX) director Kathleen Starkoff report in this Form 4?

Kathleen Starkoff reported a grant of 5,626 shares of GENTEX CORP Common Stock. The award is a compensation-related acquisition, bringing her direct holdings to 36,770 shares after the transaction as disclosed in the filing.

Is the GENTEX CORP (GNTX) Form 4 transaction a stock purchase or a grant?

The Form 4 shows a stock grant, not an open-market purchase. Starkoff received 5,626 shares with a transaction price of $0.0000 per share, classified as a “Grant, award, or other acquisition” of Common Stock.

How many GENTEX CORP (GNTX) shares does Kathleen Starkoff hold after this award?

After the reported grant, Starkoff directly holds 36,770 shares of GENTEX CORP Common Stock. This total includes the 5,626-share award disclosed in the transaction, as shown in the post-transaction holdings field of the Form 4.

What is the vesting schedule for Kathleen Starkoff’s new GENTEX CORP (GNTX) shares?

The award vests 100% one year from the grant award date. Until that vesting date, the 5,626 granted shares are subject to vesting conditions, after which Starkoff will have full ownership of the entire grant.

Does the GENTEX CORP (GNTX) Form 4 indicate any stock sales by Kathleen Starkoff?

The Form 4 does not report any sales. It shows a single acquisition transaction coded “A” for 5,626 shares as a grant or award, with no corresponding disposition or sale entries in the transaction summary.